An Insight into Different Experimental Models used for Hepatoprotective Studies: A Review

Sucharita Babu, S. K. Ranajit, G. Pattnaik, Goutam Ghosh, Goutam Rath, B. Kar
{"title":"An Insight into Different Experimental Models used for Hepatoprotective\nStudies: A Review","authors":"Sucharita Babu, S. K. Ranajit, G. Pattnaik, Goutam Ghosh, Goutam Rath, B. Kar","doi":"10.2174/0115701638278844231214115102","DOIUrl":null,"url":null,"abstract":"\n\nNumerous factors, including exposure to harmful substances, drinking too much alcohol,\ncontracting certain hepatitis serotypes, and using specific medicines, contribute to the development\nof liver illnesses. Lipid peroxidation and other forms of oxidative stress are the main mechanisms by\nwhich hepatotoxic substances harm liver cells. Pathological changes in the liver include a rise in the\nlevels of blood serum, a decrease in antioxidant enzymes, as well as the formation of free radical\nradicals. It is necessary to find pharmaceutical alternatives to treat liver diseases to increase their\nefficacy and decrease their toxicity. For the development of new therapeutic medications, a greater\nknowledge of primary mechanisms is required. In order to mimic human liver diseases, animal models are developed. Animal models have been used for several decades to study the pathogenesis of\nliver disorders and related toxicities. For many years, animal models have been utilized to investigate\nthe pathophysiology of liver illness and associated toxicity. The animal models are created to imitate\nhuman hepatic disorders. This review enlisted numerous hepatic damage in vitro and in vivo models\nusing various toxicants, their probable biochemical pathways and numerous metabolic pathways via\noxidative stressors, different serum biomarkers enzymes are discussed, which will help to identify\nthe most accurate and suitable model to test any plant preparations to check and evaluate their hepatoprotective properties.\n","PeriodicalId":502412,"journal":{"name":"Current Drug Discovery Technologies","volume":"3 10","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Drug Discovery Technologies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115701638278844231214115102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Numerous factors, including exposure to harmful substances, drinking too much alcohol, contracting certain hepatitis serotypes, and using specific medicines, contribute to the development of liver illnesses. Lipid peroxidation and other forms of oxidative stress are the main mechanisms by which hepatotoxic substances harm liver cells. Pathological changes in the liver include a rise in the levels of blood serum, a decrease in antioxidant enzymes, as well as the formation of free radical radicals. It is necessary to find pharmaceutical alternatives to treat liver diseases to increase their efficacy and decrease their toxicity. For the development of new therapeutic medications, a greater knowledge of primary mechanisms is required. In order to mimic human liver diseases, animal models are developed. Animal models have been used for several decades to study the pathogenesis of liver disorders and related toxicities. For many years, animal models have been utilized to investigate the pathophysiology of liver illness and associated toxicity. The animal models are created to imitate human hepatic disorders. This review enlisted numerous hepatic damage in vitro and in vivo models using various toxicants, their probable biochemical pathways and numerous metabolic pathways via oxidative stressors, different serum biomarkers enzymes are discussed, which will help to identify the most accurate and suitable model to test any plant preparations to check and evaluate their hepatoprotective properties.
深入了解用于肝脏保护研究的不同实验模型:综述
许多因素,包括接触有害物质、过量饮酒、感染某些肝炎血清型以及使用特定药物,都会导致肝病的发生。脂质过氧化和其他形式的氧化应激是肝毒性物质伤害肝细胞的主要机制。肝脏的病理变化包括血清水平升高、抗氧化酶减少以及自由基的形成。有必要寻找治疗肝病的药物替代品,以提高疗效,降低毒性。为了开发新的治疗药物,需要对主要机制有更深入的了解。为了模拟人类肝病,人们开发了动物模型。几十年来,动物模型一直被用于研究肝脏疾病的发病机制和相关毒性。多年来,动物模型一直被用来研究肝脏疾病和相关毒性的病理生理学。这些动物模型是模仿人类肝脏疾病而建立的。本综述列举了大量使用各种毒物的体外和体内肝损伤模型、其可能的生化途径以及通过氧化应激源的大量代谢途径,并讨论了不同的血清生物标志物酶,这将有助于确定最准确和最合适的模型来测试任何植物制剂,以检查和评估其保肝特性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信